1. Regulation of human oviductin mRNA expression in vivo
Christine Briton-Jones, B.Sc., Ingrid Hung Lok, Pong Mo Yuen, Tony Tak Yu Chiu, Lai Ping Cheung, Christopher Haines, M.D. 
Fertility and Sterility 
Volume 75, Issue 5, Pages (May 2001)
DOI: /S (01)01696-X

2. Figure 1
(A), RT-PCR oviductin product. The 410-bp oviductin band (a). The Sac 1 restriction digest of the oviductin RT-PCR product showing two bands, 235 bp and 174 bp; mw, 50-bp ladder molecular weight marker (b). (B), RT-PCR products for the control gene β-actin (543 bp) and for oviductin (410 bp). mRNA from oviductal cells obtained during the early follicular phase with low circulating concentrations of E2, LH, and P (a). mRNA from oviductal cells obtained during the late follicular phase with high circulating concentrations of E2 and LH and low concentration of P (b). mRNA from oviductal cells obtained during the luteal phase with low circulating concentrations of E2 and LH and high concentrations of P (c).
Briton-Jones. Regulation of human oviductin in vivo. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01)01696-X)

3. Figure 2
(A), Scatterplot showing the correlation between serum E2 concentration and relative oviductin mRNA expression, excluding samples obtained in the luteal phase, where P > 5 nmol/L. (B), Scatterplot showing the correlation between serum LH concentration and the relative oviductin mRNA expression. (C), Scatterplot showing the correlation between serum P concentration and the relative oviductin mRNA expression.
Briton-Jones. Regulation of human oviductin in vivo. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01)01696-X)